Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentration.

Date publication

septembre 2017

Journal

Infectious diseases (London, England)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DELMER Alain

Tous les auteurs :
Hentzien M, Strady C, Vernet-Garnier V, Servettaz A, De Champs C, Delmer A, Bani-Sadr F, N'Guyen Y

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28490261

Résumé

The impact of a minimum inhibitory concentration (MIC) of vancomycin ≥2 mg/L on mortality and the potential benefit of new antistaphylococcal treatments in coagulase-negative Staphylococcus (CoNS) bacteraemia remain unknown. We assessed the impact of vancomycin MIC on 30-day in-hospital mortality and identified factors independently associated with 30-day in-hospital mortality.

Mots clés

Coagulase-negative Staphylococcus, bacteraemia, mortality, prognosis, vancomycin

Référence

Infect Dis (Lond). 2017 Sep;49(9):664-673